| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3618e60cf45289de9b9015b0ae1614b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8f6e21b0b33bf27141cf125aceb619d3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_749f13d4be842305f9ff99387310fcba |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2081
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-194
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
| filingDate |
2010-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_716ab653a047061c6abbfb2d4b2c044c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ade7a0c937e37939afb0902145bb294
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79366fbc8ac9f2c5e5fa1458c8805496 |
| publicationDate |
2010-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2010247634-A1 |
| titleOfInvention |
Compositions and Methods for Inhibiting Gastric Acid Secretion |
| abstract |
The present invention is related to novel oral compositions comprising an irreversible gastric H+/K+-ATPase proton pump inhibitor (PPI) as a gastric acid secretion inhibitor and one or more small carboxylic acid molecules as parietal cell activators in the gastric lumen. Unexpectedly, the compositions of the present invention are capable of enhancing the anti-acid activity of PPI in the stomach. The present invention further relates to a method of using such compositions to reduce gastric acid secretion in a mammal. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9132082-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011111039-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9370481-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9278080-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9233092-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009274766-A1 |
| priorityDate |
2005-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |